Search alternatives:
d levels » _ levels (Expand Search)
decrease » increase (Expand Search)
increased » increase (Expand Search)
Showing 1 - 20 results of 420 for search '(( i ((largest decrease) OR (larger decrease)) ) OR ( d levels increased ))*', query time: 0.14s Refine Results
  1. 1

    Cardiac phosphodiesterases are differentially increased in diabetic cardiomyopathy by Hanna, Rita

    Published 2021
    “…Moreover, we noted an early and specific upregulation of cardiac PDE1A, PDE2A, PDE4B, PDE4D and PDE5A expression at week 4, followed by increases in PDE3A levels in diabetic hearts at week 8. …”
    Get full text
    Get full text
    Get full text
    Get full text
    article
  2. 2
  3. 3

    Trends and levels of the global, regional, and national burden of appendicitis between 1990 and 2021: findings from the Global Burden of Disease Study 2021 by Letourneau, Ian D

    Published 2024
    “…The global age-standardised rates of mortality, incidence, YLLs, YLDs, and DALYs due to appendicitis decreased steadily between 1990 and 2021, with the largest reduction in mortality and YLL rates. …”
    Get full text
    Get full text
    Get full text
    article
  4. 4
  5. 5
  6. 6

    Price-aware traffic splitting in D2D HetNets with cost-energy-QoE tradeoffs by Abbas, Nadine

    Published 2020
    “…An attractive enhancement technique is to utilize the co-existence of multiple interfaces in wireless devices to connect simultaneously to different access networks including cooperation over device-to-device (D2D) links. To this end, we present in this work optimized user-centric traffic splitting strategies in heterogeneous networks to achieve a high QoE level for video on demand applications with low cost and energy consumption for end users. …”
    Get full text
    Get full text
    Get full text
    Get full text
    article
  7. 7
  8. 8

    Advancements of 2D Materials-Based Membranes by Zakarya Othman (11778968)

    Published 2021
    “…Among the emerging nanomaterials, 2D nanomaterials have attracted increasing attention recently following the discovery of graphene, which quickly placed among the most promising materials due to its distinctive structures and novel properties. …”
  9. 9
  10. 10
  11. 11

    Association of Differing Qatari Genotypes with Vitamin D Metabolites by Youssra Dakroury (9991407)

    Published 2020
    “…</em>The distribution was as follows: 164 (41.2%) genotyped Q1, 149 (37.4%) genotyped Q2, 31 (7.8%) genotyped Q3, and 54 (13.6%) genotyped “admixed.” Median levels of 25(OH)D and 3epi-25(OH)D did not differ across Q1, Q2, Q3, and “admixed” genotypes, respectively. 1,25(OH)2D levels were lower (<em>p</em> < 0.04) between Q2 and the admixed groups, and 24,25(OH)2D levels were lower (<em>p</em> < 0.05) between Q1 and the admixed groups. …”
  12. 12
  13. 13
  14. 14

    Soluble Neuropilin-1 Response to Hypoglycemia in Type 2 Diabetes: Increased Risk or Protection in SARS-CoV-2 Infection? by Abu Saleh Md Moin (6189512)

    Published 2021
    “…The Renin-Angiotensin System (RAS) is activated in type 2 diabetes (T2D); therefore, the aim of this study was to determine if hypoglycaemia-induced stress in T2D would potentiate serum NRP1(sNRP1) levels, reflecting an increased risk for SARS-CoV-2 infection.…”
  15. 15
  16. 16
  17. 17

    Cognition and physical functioning in patients with schizophrenia: any role for vitamin D? by Azar, Jocelyne

    Published 2019
    “…Aim: The study’s objective was to evaluate the relationship between vitamin D (VD) levels and cognitive performance in patients with schizophrenia. …”
    Get full text
    Get full text
    Get full text
    Get full text
    article
  18. 18
  19. 19
  20. 20

    3D Tissue-Engineered Vascular Drug Screening Platforms: Promise and Considerations by Isra Marei (11312895)

    Published 2022
    “…Specifically, cardiovascular developments have been showing amongst the lowest levels of approvals. In addition, concerns over the adverse effects of drugs to the cardiovascular system have been increasing and resulting in failure at the preclinical level as well as withdrawal of drugs post-marketing. …”